MEP9808A - Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same - Google Patents

Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same

Info

Publication number
MEP9808A
MEP9808A MEP-98/08A MEP9808A MEP9808A ME P9808 A MEP9808 A ME P9808A ME P9808 A MEP9808 A ME P9808A ME P9808 A MEP9808 A ME P9808A
Authority
ME
Montenegro
Prior art keywords
delayed
patch
methods
hypersensitivity inducer
preparation
Prior art date
Application number
MEP-98/08A
Other languages
Bosnian (bs)
English (en)
Inventor
Jutaro Shudo
Ichiro Mori
Original Assignee
Teikoku Pharma Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Pharma Usa Inc filed Critical Teikoku Pharma Usa Inc
Publication of MEP9808A publication Critical patent/MEP9808A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/0276—Apparatus or processes for manufacturing adhesive dressings or bandages
    • A61F2013/0296—Apparatus or processes for manufacturing adhesive dressings or bandages for making transdermal patches (chemical processes excluded)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MEP-98/08A 2001-03-12 2002-02-22 Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same MEP9808A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27521301P 2001-03-12 2001-03-12
PCT/US2002/005641 WO2002072081A1 (en) 2001-03-12 2002-02-22 Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same

Publications (1)

Publication Number Publication Date
MEP9808A true MEP9808A (en) 2010-06-10

Family

ID=23051331

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-98/08A MEP9808A (en) 2001-03-12 2002-02-22 Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same

Country Status (22)

Country Link
US (3) US6761900B2 (no)
EP (1) EP1370251A1 (no)
JP (2) JP2004524327A (no)
KR (2) KR20090117839A (no)
CN (1) CN100594893C (no)
AU (1) AU2002247209C1 (no)
BR (1) BR0208005A (no)
CA (1) CA2440209A1 (no)
CR (1) CR7078A (no)
EA (1) EA006208B1 (no)
HK (1) HK1072364A1 (no)
IL (2) IL157795A0 (no)
ME (1) MEP9808A (no)
MX (1) MXPA03008206A (no)
NO (1) NO20033985L (no)
NZ (1) NZ528098A (no)
PL (1) PL363839A1 (no)
RS (1) RS50729B (no)
TW (1) TWI331521B (no)
UA (1) UA79587C2 (no)
WO (1) WO2002072081A1 (no)
ZA (1) ZA200306997B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6761900B2 (en) * 2001-03-12 2004-07-13 Teikoku Pharma Usa, Inc. Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same
US20030118632A1 (en) * 2001-12-26 2003-06-26 Larry Caldwell Methods and compositions for treating carpal tunnel syndrome
US7645916B2 (en) * 2003-01-23 2010-01-12 Specialty Silicone Fabricators, Inc. Elastically deformable fabric with gel coated surface
US20040147187A1 (en) * 2003-01-23 2004-07-29 Rasor Allen C. Elastically deformable fabric with gel coated surface
ITMI20030414A1 (it) * 2003-03-06 2004-09-07 Biofarm S R L Ora Biofarmitalia S P A Tampone con strato di gel con attivita' cosmetica o terapeutica.
US20060211766A1 (en) * 2004-09-30 2006-09-21 Kaplan Leonard L Gelled immunomodulating topical compositions and a method of treating warts and other human papilloma virus skin infections
US8080261B2 (en) * 2004-09-30 2011-12-20 Teikoku Pharma Usa, Inc. 1-chloro-2,4-dinitrobenzene non-aqueous gel compositions and methods for using the same
AP2007003963A0 (en) * 2004-09-30 2007-04-30 Teikoku Pharma Usa Inc 1-Chloro-2,4-dinitrobenzene gel compositions and methods for using the same
AU2005323206C1 (en) * 2005-01-04 2010-01-07 Teikoku Pharma Usa, Inc. Cooling topical patch preparation
EP1940377A4 (en) * 2005-10-24 2010-12-08 Teikoku Pharma Usa Inc TOPICAL AEROSPECTIVE COMPOSITIONS OF N, 2,3-TRIMETHYL-2-ISOPROPYLBUTAMIDE AND METHOD OF USE THEREOF
JP5010829B2 (ja) * 2005-12-28 2012-08-29 帝國製薬株式会社 貼付剤
JP5010834B2 (ja) * 2006-02-20 2012-08-29 帝國製薬株式会社 貼付剤
KR101352238B1 (ko) 2007-04-04 2014-01-15 더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 단순포진바이러스 감염 치료를 위한 비특이적 지연형 과민증 반응
WO2009005814A2 (en) * 2007-07-03 2009-01-08 Marchitto Kevin S Drug-delivery patch comprising a dissolvable layer and uses thereof
EP3494790A1 (en) 2010-03-02 2019-06-12 Phio Pharmaceuticals Corp. Effective sensitizing dose of a gelled immunomodulating topical composition
EP3087985B1 (en) * 2013-12-18 2018-10-17 Maruishi Pharmaceutical Co., Ltd. Hydrous adhesive patch
US20160279083A1 (en) * 2015-02-24 2016-09-29 Moein Health, Inc. Topical treatment for cervical intraepithelial neoplasia
US10588564B2 (en) 2014-09-30 2020-03-17 Moein Health, LLC Method and kit for diagnosing and treating neoplastic tissue
EP3261654B1 (en) 2015-02-26 2021-08-11 Squarex, LLC Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection
KR101646181B1 (ko) 2015-08-18 2016-08-05 한양대학교 에리카산학협력단 이리노테칸 함유 이중역상 온도감응성 수용성 겔 조성물
US10371610B2 (en) 2016-02-23 2019-08-06 Noul Co., Ltd. Contact-type patch, staining method using the same, and manufacturing method thereof
KR20170099737A (ko) 2016-02-23 2017-09-01 노을 주식회사 접촉식 염색 패치 및 이를 이용하는 염색 방법
BR112021011103A8 (pt) * 2018-12-18 2022-08-09 Currahee Holding Company Inc Emplastro personalizado para aplicação tópica
CN112315661A (zh) * 2020-10-26 2021-02-05 广东泰宝医疗科技股份有限公司 一种持效期长的离子感应贴

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2375861A1 (fr) 1976-12-31 1978-07-28 Merieux Inst Tampon adhesif pour tests epicutanes
US4129547A (en) * 1977-06-30 1978-12-12 E. I. Du Pont De Nemours And Company High solids coating compositions for flexible substrates containing urea-formaldehyde
US4129647A (en) 1977-10-17 1978-12-12 Edmund Klein Treatment of acne
US4897260A (en) * 1987-05-22 1990-01-30 The Rockefeller University Compositions that affect suppression of cutaneous delayed hypersensitivity and products including same
US5476664A (en) * 1994-04-15 1995-12-19 Leonard Bloom Treatment of warts using anthralins and occlusion
DE69524614T2 (de) * 1994-10-05 2002-09-12 Hisamitsu Pharmaceutical Co Arzneimittelbestandteile einschliesslich eines n-substituierten o-toluidinderivats und transdermal absorbierbare zubereitung
AU5543196A (en) * 1995-04-12 1996-10-30 Robert B. Hopp Skin patch for use in contact immunotherapy
JPH11171768A (ja) 1997-10-15 1999-06-29 Taisho Pharmaceut Co Ltd 消炎鎮痛外用剤
WO2001047559A1 (fr) 1999-12-27 2001-07-05 Teikoku Seiyaku Co., Ltd Pastilles a usage externe
US6761900B2 (en) * 2001-03-12 2004-07-13 Teikoku Pharma Usa, Inc. Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same

Also Published As

Publication number Publication date
NZ528098A (en) 2004-04-30
KR20030088457A (ko) 2003-11-19
UA79587C2 (en) 2007-07-10
JP2004524327A (ja) 2004-08-12
RS50729B (sr) 2010-08-31
JP2010013474A (ja) 2010-01-21
MXPA03008206A (es) 2004-11-12
CN100594893C (zh) 2010-03-24
US20040219200A1 (en) 2004-11-04
IL157795A0 (en) 2004-03-28
TWI331521B (en) 2010-10-11
CR7078A (es) 2004-03-10
EA200300995A1 (ru) 2004-02-26
KR20090117839A (ko) 2009-11-12
CN1561202A (zh) 2005-01-05
WO2002072081A1 (en) 2002-09-19
HK1072364A1 (en) 2005-08-26
EP1370251A1 (en) 2003-12-17
BR0208005A (pt) 2004-03-02
NO20033985D0 (no) 2003-09-09
CA2440209A1 (en) 2002-09-19
IL157795A (en) 2007-08-19
AU2002247209B2 (en) 2005-11-17
ZA200306997B (en) 2004-09-08
PL363839A1 (en) 2004-11-29
US6761900B2 (en) 2004-07-13
NO20033985L (no) 2003-11-03
US20040219199A1 (en) 2004-11-04
US20020176886A1 (en) 2002-11-28
EA006208B1 (ru) 2005-10-27
AU2002247209C1 (en) 2006-08-10
YU70703A (sh) 2006-05-25

Similar Documents

Publication Publication Date Title
MEP9808A (en) Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same
ATE275971T1 (de) Sonodynamische therapie mit ultraschalsensibilisator
HUP0102899A2 (hu) Eljárás gyulladásgátló, különösen fertőtlenítő hatású és/vagy sebgyógyulást elősegítő szerek alsó légutakba történő beadására szolgáló készítmények előállítására
HK1108350A1 (en) Cooling topical patch preparation
DE69613840T2 (de) Orale dosierungsform und verfahren zur behandlung von schmerzzuständen in dermundhöhle
JP2004524327A5 (no)
ID27503A (id) Tts yang mengandung antioksidan
RS50086B (sr) Upotreba antagonista subjedinica alfa-4 integrina za pripremanje farmaceutskog preparata za tretiranje fibroze
DE50114474D1 (de) Kombination eines transdermalen therapeutischen systems und einer oralen und/oder parenteralen zubereitung enthaltend dopaminagonisten zur behandlung dopaminerger erkrankungen
KR100202834B1 (ko) 탈모 예방 및 발모촉진 머릿기름의 제조방법
KR101460368B1 (ko) 탈모 방지 또는 모발 성장 촉진용 패치제
ATE445409T1 (de) Zusammensetzungen mit matrixproteinen zur regeneration von dentin
ES2163805T3 (es) Derivados de acidos benzofurano-acrilicos y su utilizacion como moduladores de los receptores rxrs o rars.
SE9800025D0 (sv) Preparat för tandbehandling
IL146132A0 (en) Preparations for the application of anti-infective and/or anti-inflammatory agents to external or internal parts of the human or animal body in functional and cosmetic tissue remodelling and repair treatments
GEP20022751B (en) Aqueous Pharmaceutical Composition Comprising an Active Ingredient Which Is Highly Insoluble in Water
ATE367806T1 (de) Mittel und verfahren zur vorbeugung von durch chemotherapie ausgelöster alopezie
EP1072261A3 (en) Felbinac-containing patch
JP2009023922A (ja) 肩こり・五十肩・各種関節痛等の改善を目的とした塗布剤
BRPI0417692A (pt) uso de uma composição, método de redução dos efeitos do estresse mediado psicologicamente na pele de um ser humano ou animal, composição, suplemento nutritivo, composição cosmética, e, método para identificar um composto capaz de reduzir os efeitos e método de produção de uma composição para a redução dos efeitos, do estresse mediado psicologicamente sobre a pele de um ser humano ou animal
JPH0778026B2 (ja) 皮膚用外用基剤
FR2786699B1 (fr) Medicament destine notamment a prevenir ou traiter les dysfonctions sexuelles
BR0308156A (pt) Composições farmacêuticas sólidas contendo lumiracoxib
RU96107872A (ru) Крем для кожи лица "talita"
KR101544182B1 (ko) 한방 샴푸 제조방법